Growth on track, margin pressure evident; capex ramp ahead
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Reaffirmed India mid-to-high teens and consol 10-12% guidance; +16.3% YoY delivery aligns. Advantek PAT timing slipped.
Cautiously Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Q2 growth +16.3% YoY validates mid-to-high teens India guidance, but OPM 17% vs 20-22% target and Romania ₹10-12 Cr losses FY27 compress near-term PAT. Long-term very optimistic (30% Bushing/Stamping growth, INR75 Cr resourcing, INR150+ Cr capex expansion with renewable/windmill tailwinds), but 12-15 month capex execution and metal price volatility are near-term headwinds.
₹440.1 Cr
Revenue · +16.3% YoY₹45 Cr
Reported PAT · +23.6% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Strong 24% H1 line growth
OVERSTATEDH1 consolidated revenue growth (implied) ~16-17% based on YoY; India segment higher per mgmt
India high-teens growth FY27
METQ2 YoY +16.3% consol; India portion claimed ~22% H1 YoY by CFO
Margin 20-22% sustainable at longer horizon
MISSQ2 OPM 17.0%, NPM 10.1%; India Engineering EBITDA 23.7% but dragged by Solar 9% revenue, Romania losses
Bushing/Stamping each 30% growth FY27
UnverifiedNot visible in Q2 consolidated numbers; claimed as forward-looking; no breakout given this quarter
Advantek on track, PAT positive FY27
OVERSTATEDAdvantek guidance ₹140 Cr reaffirmed but Q1 losses ~₹7 Cr; H2 expected to improve, not yet positive
Earnings quality
What changed since the last call
Advantek PAT timing deferred
DowngradePrior call promised FY27 PAT positive; now saying H2 improvement, Q1 showed ₹7 Cr loss. Full-year PAT still expected positive per Q&A, but near-term drag acknowledged.
Romania loss quantum flagged
DowngradeWas vague prior call; now management saying FY27 loss will be 'much lower' but didn't quantify. Analyst extrapolated ₹10-12 Cr from context (vs ₹14 Cr FY26).
Capex acceleration committed
UpgradePrior guidance ₹50-80 Cr FY27; now managing 12-15 month timeline for INR220 Cr Advantek+China phases. Incremental borrowing approved per CFO; front-loading capex spend.
India growth pace reaffirmed
NeutralStill mid-to-high teens; +22% H1 YoY (India segment) claimed vs prior 'high-teens' target. On track but not raised.
Consol guidance maintained at 10-12%
NeutralNo change from Q1 call; current +16.3% consol YoY is ABOVE this range, but mgmt cautious on H2 seasonality, Romania, China softness.
The Q&A
Analysts pressed hard on Romania losses (deferred), Advantek capex breakup (eventually clarified), Stamping margin dilution (acknowledged but not detailed), China growth (defended 5-7% forward plan). Management held guidance but didn't volunteer pain points; tone defensive, not dismissive.
Romania profitability — Nisarg Shah, Pkeday Investment Office
DodgedToo premature to give timeline. Evaluating and will update next quarter. Focus is to arrest losses and achieve operating profitability, not net profit yet.
Margin breakdown — Varun Jain, Dolat Capital
PartialMix of both. Brass price (copper/zinc) up 6 months, passed 50% through. Solar lower margin contributed. But better product mix within India Engineering.
H2 guidance conservatism — Harshit Patel, Equirus Securities
AnsweredCautious on China (soft), Romania uncertainty, Q3 seasonally soft historically. But nothing negative implied; just being prudent given headwinds.
Long-term capacity vision — Prasenjit Paul, 129 Wealth Fund
AnsweredFrom long-term view, INR2,500-3,000 Cr consol revenue potential, combination of existing capacity utilization and new greenfield investment. Margin 20% plus sustainable at longer horizon.
Romania EBITDA — Koustav, Paul Asset
DodgedWorking on it. Too early. Challenges in cost structure. Will update quarterly.
Capex split and timing — Aditya, Old Bridge Mutual Fund
AnsweredIndia Advantek ~INR110 Cr, China ~INR100 Cr for expansion; total INR220 Cr over 12-15 months case-by-case. Maintenance capex ~INR25-30 Cr consol/year.
Stamping segment margin — Varun Jain, Dolat Capital
DodgedWe don't share breakdown further. Growth is expected; margins will follow.
China growth recovery — Prolin Nandu, Edelweiss Public Alternatives
PartialModerate 5%-7% growth expected. Improvement when new capacity comes; bigger jump post-commercialization Q3 FY28. Right now steady improvement in sales + new products.
Resourcing project scope — Manish Goyal, ThinkWise Wealth Managers
AnsweredOne project INR70-75 Cr annual revenue at peak. Cages side components INR20-30 Cr; aerospace/defense opportunities small but growing. Commercialization Q3/Q4 FY27.
Bushing market opportunity — Manish Goyal, ThinkWise Wealth Managers
PartialLarge windmill bearings 5-8 MW require many Bushings. We're capturing large share incrementally. 16-megawatt windmill now in supply. Bushing part of larger play, not isolated.
Guidance
FY27 India mid- to high-teens growth
HighH1 actual +22% YoY (India segment); Q3 seasonality noted. Management cautious but on trajectory. Bushing/Stamping 30% growth drivers.
FY27 Consol 10%-12% growth
MediumCurrent +16.3% YoY well above guide; offset by China (1% Q2) and Romania (loss). Management says caution on H2 due to seasonality, headwinds; may miss lower end of range or hit higher.
India EBITDA margin 22% sustainable long-term
MediumQ2 India Engineering EBITDA 23.7% achieved; but consol OPM only 17% due to Solar (9% revenue, lower margin) and new capex interest starting. Guidance 20-22% OPM long-term not yet in sight.
Consol EBITDA margin 17%-18% for Engineering business
MediumManagement stated range in call; aligns with current 17% OPM if Solar/Advantek losses improve. Metal price volatility noted as ongoing headwind (absorption lag).
FY27 Capex ₹50-80 Cr (prior); now INR150+ Cr over 12-15 months
HighAdvantek INR110 Cr, China INR100 Cr; split across multiple years. H1 cumulative INR70+ Cr on track. Incremental borrowing approved; targeting completion by June 2027 milestone.
Risks the call surfaced
Romania loss containment
HighFY26 loss ₹14 Cr; FY27 estimated ₹10-12 Cr by analysts (mgmt didn't quantify). Downsizing strategy deferred; capex absorption & restructuring costs not detailed.
China market softness
MediumQ2 FY27 growth only 1% YoY; management guiding 5-7% forward. Soft demand in sequential basis vs India. INR100 Cr capex expansion in uncertain market adds execution risk.
Margin compression from capex
MediumQ2 OPM 17% vs 20-22% guidance. New capex (INR150+ Cr) will incur interest & depreciation starting Q3 FY27. Near-term PAT pressure before commercialization revenue arrives (Q3/Q4 FY27).
Metal price volatility
MediumBrass prices (copper/zinc) up 6 months; management passing through ~50% to customers. Remaining 50% absorbed, impacting margins. Volatility expected to continue; customer contracts may resist further increases.
Capex execution & commercialization timing
MediumINR150+ Cr capex (Advantek INR110 Cr, China INR100 Cr) targeted 12-15 months completion. Customer approval delays possible; commercialization timeline (Q3/Q4 FY27 for Cage, Q3 FY28 for China) uncertain. Near-term cash burn with deferred revenue uplift.
Resourcing project commercialization risk
LowResourcing/outsourcing project (Europe/US) expected to start commercial sales Q3/Q4 FY27. Peak INR75 Cr run-rate is 12-24 months away. Customer approval delays or volume ramp slower than expected.
Management
Score 6/10. Clear on business color (Cage demand, Bushing ramp, Japan growth), but evasive on sensitive topics. Romania losses deferred; Advantek PAT H1 not volunteered; Stamping margin breakdown withheld. Standard disclosures met; transparency selectively applied. India business on track (+22% H1 YoY, high-teens growth reaffirmed); capex acceleration shows decisiveness (12-15 months vs prior 18 months). Advantek profitability deferred (₹7 Cr H1 loss vs prior positive expectation); missed near-term margin targets (17% OPM vs 20-22%).
1 · Q3/Q4 FY27
Resourcing outsourcing project commercial sales commence; INR75 Cr peak run-rate opportunity
2 · Q3 FY27
China brownfield expansion commences production; adds ~5-7% growth to softened base
3 · H2 FY27
Advantek expansion capacity online; profitability inflection expected; capex ₹110 Cr ongoing
Long-term very optimistic (30% Bushing/Stamping growth, INR75 Cr resourcing, INR150+ Cr capex expansion with renewable/windmill tailwinds), but 12-15 month capex execution and metal price volatility are near-term headwinds.
Informational and educational content only. Not investment advice.